IMPORTANT LEGAL NOTICE - The information on this site is subject to a disclaimer and a copyright notice.

European Flag

   EuropaThe European CommissionResearchPress releases

Brussels, 8 October 1999

Recent European advances in biotechnology

Cell factory Press Conference: Detailed project information

On 29 October, six European research projects that are making significant advances in life sciences and technologies, will be presented to the press by the researchers involved. These projects will have an impact on healthcare, food production and industrial processes.

The "Cell Factory FP4" conference will take place in Graz, Austria from 27-30 October. In the framework of this meeting the project coordinators of all EU-sponsored projects in this area will present their results and their impact. In addition, a press conference is scheduled on Friday 29 October at the Grazer Congress Centre. The research projects to be presented cover a range of applications including the development of oral vaccines, the production of industrial enzymes, their use to produce fine chemicals, or finding ways of reducing use of chemicals in agriculture (see programme below).

Journalists interested in attending the press conference are urged to notify Stéphane Hogan or Clemens Keil as soon as possible so that practical arrangements can be made. The press conference is from 10:00 to 12:00, followed by lunch.

This initiative of the Research Directorate of the European Commission, which implements the European Union's R&D programmes, is part of a series of press briefings designed to highlight the advances made in the framework of the EU's Life Science programmes.

For further information, please contact:

Stéphane Hogan
Research DG
Fax: +32 2 299.18.60
E-mail: Research Contact

Astrid Preisz and Clemens Keil
Technical University of Graz
Tel:+43 316 873 8741
Fax:+43 316 35 1314

Graz, 29 October 1999 - Press briefing - Programme


Project title


  • Introduction to the EC’s R&D programmes
S. Hogan
European Commission
  • Using enzymes to produce fine chemicals
Prof. H. Griengl,
Technische Universität Graz (AT)
  • Lactic acid bacteria as oral vaccines
Dr. Annick Mercenier,
Institut Pasteur de Lille (FR).
  • Extremophiles as cell factories
Prof. Garo Antranikian,
Univ. Hamburg-Harburg (DE)
  • Stem cells to produce human tissue engineered organs
Dr. J. Hatzfeld,
CNRS, Paris (FR)
  • Production of fungal antagonists for use as biological control agents
Dr. R. M. Buitelaar, ATO-DLO, Wageningen, (NL)
  • New methods of vaccine production
Dr. I. Casal, Ingenasa (ES)
  • Developments for the future: FP-5
T. Ingemansson,
European Commission

The full conference programme is available on the Web:

For information about the congress venue:

For more information about the European Union's research activities in the field of life sciences and technologies:

Search Top